Title:
免疫療法で使用するための新規ペプチドおよびペプチド組み合わせおよび膵臓がんおよびその他のがんに対して使用するためにスキャフォールドを作製する方法
Document Type and Number:
Japanese Patent JP7116149
Kind Code:
B2
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
More Like This:
Inventors:
Andrea, Mare
Weinschenk, Toni
Shall, Oliver
Fritche, jens
Shin, Harpreet
Weinschenk, Toni
Shall, Oliver
Fritche, jens
Shin, Harpreet
Application Number:
JP2020210857A
Publication Date:
August 09, 2022
Filing Date:
December 19, 2020
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C12N15/12; A61K31/7088; A61K35/12; A61K35/76; A61K38/08; A61K38/10; A61K39/00; A61K39/395; A61K48/00; A61P1/18; A61P35/00; A61P35/02; A61P37/04; C07K14/725; C07K16/30; C07K19/00; C12N5/0783; C12N5/10; C12N15/115; C12N15/62; C12N15/63; C12P21/02; G01N33/53
Domestic Patent References:
JP2007535330A | ||||
JP2009292810A |
Foreign References:
WO2013148325A1 | ||||
US20150125477 | ||||
WO2015063302A2 |
Other References:
PLOS ONE,2013年,8(5),e64235
Cellular Physiology and Biochemistry,2015年02月,35,983-996
Mol. Cell. Biochem.,2013年,376,21-32
Cellular Physiology and Biochemistry,2015年02月,35,983-996
Mol. Cell. Biochem.,2013年,376,21-32
Attorney, Agent or Firm:
Go Akatsu
Previous Patent: Novel peptides and peptide combinations for use in immunotherapy and methods of making scaffolds for...
Next Patent: 安息香酸誘導体
Next Patent: 安息香酸誘導体